Peter Altman - Apr 14, 2022 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role: President and CEO, Director
Signature: /s/ David McClung, by power of attorney
Stock symbol: BCDA
Transactions as of: Apr 14, 2022
Transactions value $: $18,700
Form type: 4
Date filed: 4/18/2022, 09:17 PM
Previous filing: Apr 14, 2023
Next filing: May 2, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BCDA	Common Stock	Award	$0	+76.7K	+32.25%	$0.00	315K	Apr 14, 2022	Direct	F1
transaction	BCDA	Common Stock	Purchase	$18.7K	+13.5K	+4.29%	$1.39	328K	Apr 18, 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BCDA	Stock Option (right to buy)	Award	$0	+141K		$0.00	141K	Apr 14, 2022	Common Stock	141K	$1.49	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on April 14, 2022.
F2	This transaction was executed in multiple trades ranging from $1.37 to $1.40 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F3	The option vests and becomes exercisable as to 1/48th of the shares on May 14, 2022, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.